Publications by authors named "Alba Font-Tello"

Claim this Profile
D
Discovery of BMS-986408, a First-In-Class Dual DGKα and DGKζ Inhibitor that Unleashes PD-1 Checkpoint and CAR T-cell Immunotherapies.
Michael Wichroski, Si-Qi Liu, Lauren M Zasadil, Joseph L Benci, Patrick C Gedeon

Cancer Immunol Res· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneity and transcriptional drivers of triple-negative breast cancer.
Bojana Jovanović, Daniel Temko, Laura E Stevens, Marco Seehawer, Anne Fassl, Alba Font-Tello

Cell Rep· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor-Positive Breast Cancer.
Francisco Hermida-Prado, Yingtian Xie, Shira Sherman, Zsuzsanna Nagy, Douglas Russo, Alba Font-Tello

Cancer Res· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of spatial transcriptomics for oncology discovery.
Anna Lyubetskaya, Brian Rabe, Andrew Fisher, Anne Lewin, Isaac Neuhaus, Alba Font-Tello

Cell Rep Methods· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Distinct Chromatin State Drives Therapeutic Resistance in Invasive Lobular Breast Cancer.
Agostina Nardone, Xintao Qiu, Sandor Spisak, Zsuzsanna Nagy, Ariel Feiglin, Alba Font-Tello

Cancer Res· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FGFR-inhibitor-mediated dismissal of SWI/SNF complexes from YAP-dependent enhancers induces adaptive therapeutic resistance.
Yihao Li, Xintao Qiu, Xiaoqing Wang, Hui Liu, Renee C Geck, Alba Font-Tello

Nat Cell Biol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting master transcription factors from pan-cancer expression data.
Jessica Reddy, Marcos A S Fonseca, Rosario I Corona, Robbin Nameki, Felipe Segato Dezem, Alba Font-Tello

Sci Adv· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subtype heterogeneity and epigenetic convergence in neuroendocrine prostate cancer.
Paloma Cejas, Yingtian Xie, Alba Font-Tello, Klothilda Lim, Sudeepa Syamala

Nat Commun· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade.
Shengqing Stan Gu, Wubing Zhang, Xiaoqing Wang, Peng Jiang, Nicole Traugh, Alba Font-Tello

Cancer Discov· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A hotspot mutation in transcription factor IKZF3 drives B cell neoplasia via transcriptional dysregulation.
Gregory Lazarian, Shanye Yin, Elisa Ten Hacken, Tomasz Sewastianik, Mohamed Uduman, Alba Font-Tello

Cancer Cell· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CDK4/6 inhibition reprograms the breast cancer enhancer landscape by stimulating AP-1 transcriptional activity.
April C Watt, Paloma Cejas, Molly J DeCristo, Otto Metzger-Filho, Enid Y N Lam, Alba Font-Tello

Nat Cancer· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ERG-Mediated Coregulator Complex Formation Maintains Androgen Receptor Signaling in Prostate Cancer.
Neel Shah, Nikolas Kesten, Alba Font-Tello, Matthew E K Chang, Raga Vadhi

Cancer Res· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FiTAc-seq: fixed-tissue ChIP-seq for H3K27ac profiling and super-enhancer analysis of FFPE tissues.
Alba Font-Tello, Nikolas Kesten, Yingtian Xie, Len Taing, Damir Varešlija

Nat Protoc· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate cancer reactivates developmental epigenomic programs during metastatic progression.
Mark M Pomerantz, Xintao Qiu, Yanyun Zhu, David Y Takeda, Wenting Pan, Alba Font-Tello

Nat Genet· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.
Shaokun Shu, Hua-Jun Wu, Jennifer Y Ge, Rhamy Zeid, Isaac S Harris, Alba Font-Tello

Mol Cell· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Androgen Receptor Is a Non-canonical Inhibitor of Wild-Type and Mutant Estrogen Receptors in Hormone Receptor-Positive Breast Cancers.
Suriyan Ponnusamy, Sarah Asemota, Lee S Schwartzberg, Fouzia Guestini, Keely M McNamara, Alba Font-Tello

iScience· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Publisher Correction: Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors.
Paloma Cejas, Yotam Drier, Koen M A Dreijerink, Lodewijk A A Brosens, Vikram Deshpande, Alba Font-Tello

Nat Med· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors.
Paloma Cejas, Yotam Drier, Koen M A Dreijerink, Lodewijk A A Brosens, Vikram Deshpande, Alba Font-Tello

Nat Med· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ERG overexpression plus SLC45A3 (prostein) and PTEN expression loss: Strong association of the triple hit phenotype with an aggressive pathway of prostate cancer progression.
Silvia Hernández-Llodrà, Nuria Juanpere, Silvia de Muga, Marta Lorenzo, Joan Gil, Alba Font-Tello

Oncotarget· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FOXO1 down-regulation is associated with worse outcome in bladder cancer and adds significant prognostic information to p53 overexpression.
Josep Lloreta, Alba Font-Tello, Núria Juanpere, Albert Frances, Marta Lorenzo

Hum Pathol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancer-Mediated Oncogenic Function of the Menin Tumor Suppressor in Breast Cancer.
Koen M A Dreijerink, Anna C Groner, Erica S M Vos, Alba Font-Tello, Lei Gu

Cell Rep· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concurrent TMPRSS2-ERG and SLC45A3-ERG rearrangements plus PTEN loss are not found in low grade prostate cancer and define an aggressive tumor subset.
Silvia Hernández, Alba Font-Tello, Núria Juanpere, Silvia de Muga, Marta Lorenzo

Prostate· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of ERG and TMPRSS2-ERG with grade, stage, and prognosis of prostate cancer is dependent on their expression levels.
Alba Font-Tello, Núria Juanpere, Silvia de Muga, Marta Lorenzo, José A Lorente

Prostate· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis